Precigen to participate in the oppenheimer 34th annual healthcare life sciences conference

Germantown, md. , feb. 6, 2024 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced helen sabzevari, phd, president and ceo of precigen, will participate in the oppenheimer 34th annual healthcare life sciences conference taking place virtually from february 13 to february 14, 2024.
PGEN Ratings Summary
PGEN Quant Ranking